Aupeg 3750IU/5ml

Indication & Dosage :
AUPEG (Pegaspargase), Generic  ONCASPAR  is a prescription medicine used to treat of acute Lymphoblastic Leukemia (ALL) in both pediatric and adult patients. Pegaspargase is commonly administered as part of a multi-agent chemotherapeutic regimen, which may include drugs such as anthracyclines, vincristine, and corticosteroids. The mechanism of action of Pegaspargase involves the depletion of the amino acid asparagine, which is essential for the survival of tumor cells. By depriving the tumor cells of asparagine, Pegaspargase induces apoptosis, leading to the death of the malignant cells. This medication is typically delivered through intravenous infusion or intramuscular injection, depending on the specific treatment protocol and patient needs. AUPEG is manufactured by by Kings Global Biotech Ltd. in India. Pegaspargase medication is given by injection into a vein by a health care professional, usually once a day. It should be injected slowly over 2 hours.  Dosage is based on Patient`s medical condition, body size, and response to treatment.
Side Effects :
The most common side effects of Pegaspargase are: Nausea, vomiting, weakness, diarrhea, or pain/swelling/redness.The above information comes from the Internet. Please consult with doctor for medical advice.
Suggestion :
* Any advice on the use of the drug is for reference only. Please consult with doctor for medical advice. All Names, logos, trademarks are property of their respective owners. Watermarks, QR code used for identification purposes only.